Regulation of Arf GTPase activation at the Golgi complex
高尔基复合体 Arf GTP 酶激活的调节
基本信息
- 批准号:9415454
- 负责人:
- 金额:$ 31.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2021-01-31
- 项目状态:已结题
- 来源:
- 关键词:AGFG1 geneBindingBiochemicalBiochemistryBiological AssayC-terminalCell SurvivalCellsCellular MembraneCellular biologyChimera organismCollectionComplexDataDefectEukaryotic CellFeedbackFundingGeneticGoalsGolgi ApparatusGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHumanIn VitroIncomeInvestigationLinkLogicMeasuresMembraneMembrane Protein TrafficModelingMolecularOrganellesOutcome StudyPathway interactionsProcessProtein SortingsProteinsRegulationRoleSNAP receptorSaccharomycetalesSignal TransductionSorting - Cell MovementVesicleYeast Model SystemYeastshuman diseasein vitro Assayin vivointermolecular interactionnovelrecruitstructural biologytemperature sensitive mutanttraffickingtrans-Golgi Networkyeast genetics
项目摘要
Project Summary/Abstract
The Golgi complex is the central sorting station for nearly a third of all proteins in eukaryotic cells, but
how cells regulate the complex flow of material through this organelle remains largely unknown. Protein and
membrane traffic at the Golgi is controlled by Arf GTPases that function by recruiting effectors to make
outgoing vesicles and tether incoming vesicles. The master regulators that activate Arf GTPase pathways are
Arf-GEFs (guanine nucleotide exchange factors). In order to understand the molecular logic of Golgi
trafficking, we must understand how the Golgi Arf-GEFs are regulated to make the molecular decision of
where and when to activate their substrate Arf proteins. We have uncovered regulatory mechanisms that
govern the function of the trans-Golgi network (TGN)-localized Arf-GEF, Sec7. We discovered that Sec7 can
switch between autoinhibited and activated states, and is regulated by direct interactions with the activated
forms of four different Golgi GTPases: Ypt31/32 (Rab11), Ypt1 (Rab1), Arl1, and Arf1. This collection of
interactions represents a previously unappreciated level of crosstalk between these prominent Golgi GTPase
pathways. Key questions remain regarding the biochemical basis for Sec7 regulation and the cell biology
underpinning these interactions. Furthermore, we have determined that Gea1 and Gea2, the Arf-GEFs that
localize to early Golgi compartments, are regulated through mechanisms that are distinct from those of Sec7.
Our long-term goal is to determine how cells regulate trafficking at the Golgi complex. In order to both
broaden and deepen our mechanistic understanding of the regulation of Arf activation at the Golgi, we
propose the following Aims for this project: 1) Investigate the intra-molecular and inter-molecular
interactions that regulate Sec7. We will use our established in vitro assays to characterize a newly identified
functional link between distinct Sec7 regulatory domains. Using a new assay for measuring Sec7 activity in
vivo, we will explore the possibilities that Sec7 integrates multiple GTPase signals and can sense and respond
to changes in Golgi cargo load. We will perform an intragenic suppressor screen to identify new functional
connections between Sec7 regulatory domains. Finally, we will seek additional structural information
regarding the Sec7 C-terminal regulatory domains. 2) Determine the mechanisms regulating localization and
activity of the early-Golgi Arf-GEFs Gea1/2. In order to understand how trafficking is regulated at the early-
Golgi, we will perform a comprehensive investigation of the mechanisms regulating Gea1/2 membrane
localization and activity. We will utilize chimeras and temperature sensitive-mutants to identify and
characterize the regions of Gea1/2 regulating localization and activity. We will combine in vitro and in vivo
approaches to characterize the roles of Gea1/2 binding partners. Finally, we will seek structural information to
explain the basis for Gea1/2 regulation. We expect the outcome of these studies will be new and refined
mechanistic models for regulation of trafficking at the Golgi complex.
项目摘要/摘要
高尔基体络合物是真核细胞中所有蛋白质近三分之一的中心分类站,但
细胞如何调节材料通过该细胞器的复杂流仍然很大程度上未知。蛋白质和
高尔基的膜流量由ARF GTPases控制,该ARF GTPase通过招募效应子来发挥作用
外向的囊泡和系绳传入囊泡。激活ARF GTPase途径的主调节器是
ARF-GEF(鸟嘌呤核苷酸交换因子)。为了了解高尔基的分子逻辑
贩运,我们必须了解如何调节高尔基Arf-gef,以做出分子决定
在何时何地激活其底物ARF蛋白。我们有发现的监管机制
控制反式高尔基网络(TGN)局部的ARF-GEF的功能,SEC7。我们发现Sec7可以
自抑制和激活状态之间的切换,并通过与激活的直接相互作用进行调节
四种不同的高尔基GTPase的形式:YPT31/32(RAB11),YPT1(RAB1),ARL1和ARF1。这个集合
相互作用代表了这些突出的高尔基GTPase之间先前未欣赏的串扰水平
途径。关于SEC7调节和细胞生物学的生化基础,仍然存在关键问题
支撑这些相互作用。此外,我们已经确定GEA1和GEA2,ARF-GEFS
本地化到早期高尔基体的隔室是通过与SEC7不同的机制来调节的。
我们的长期目标是确定细胞如何调节高尔基体复合物的运输。为了两者
扩大和加深我们对高尔基体ARF激活调节的机械理解,我们
提出以下目标的目的:1)研究分子内和分子间
调节SEC7的相互作用。我们将使用我们既定的体外测定法来表征新鉴定的
不同的SEC7调节域之间的功能联系。使用新的测定法来测量SEC7活动
Vivo,我们将探讨SEC7集成多个GTPase信号的可能性,并可以感知和回应
高尔基货物负载的变化。我们将执行基因内抑制器屏幕以识别新功能
SEC7监管域之间的连接。最后,我们将寻求其他结构信息
关于SEC7 C末端调节域。 2)确定调节本地化的机制和
早期Golgi ARF-GEFS GEA1/2的活性。为了了解在早期如何调节贩运的方式
高尔基,我们将对调节GEA1/2膜的机制进行全面研究
本地化和活动。我们将利用嵌合体和温度敏感的突击剂来识别和
表征调节定位和活性的GEA1/2区域。我们将在体外和体内结合
表征GEA1/2结合伙伴角色的方法。最后,我们将寻求结构信息
解释GEA1/2调节的基础。我们预计这些研究的结果将是新的和精致的
调节高尔基综合体贩运的机械模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J Christopher Fromme其他文献
J Christopher Fromme的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J Christopher Fromme', 18)}}的其他基金
GTPase Regulation of the Golgi Complex (Diversity Supplement 2023)
高尔基复合体的 GTPase 调节(多样性补充资料 2023)
- 批准号:
10800329 - 财政年份:2020
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Rab activation at the Golgi complex
高尔基复合体 Rab 激活的调节
- 批准号:
9005350 - 财政年份:2016
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Rab activation at the Golgi complex
高尔基复合体 Rab 激活的调节
- 批准号:
9197321 - 财政年份:2016
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Arf GTPase activation at the Golgi complex
高尔基复合体 Arf GTP 酶激活的调节
- 批准号:
9234934 - 财政年份:2012
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Arf GTPase activation at the trans-Golgi network
跨高尔基体网络 Arf GTPase 激活的调节
- 批准号:
8245998 - 财政年份:2012
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Arf GTPase activation at the trans-Golgi network
跨高尔基体网络 Arf GTPase 激活的调节
- 批准号:
8413049 - 财政年份:2012
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Arf GTPase activation at the trans-Golgi network
跨高尔基体网络 Arf GTPase 激活的调节
- 批准号:
9000156 - 财政年份:2012
- 资助金额:
$ 31.1万 - 项目类别:
相似国自然基金
拟南芥中EIN2蛋白调控mRNA翻译并激活乙烯信号的生化机制研究
- 批准号:31870254
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
大米蛋白/阿魏酸的结合机制对复合物的抗氧化及模拟胃肠消化性能的调控研究
- 批准号:31760433
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
拟南芥fimbrin5调控花粉管生长的细胞学基础和生化机制分析
- 批准号:31671390
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
拟南芥微丝解聚因子第三亚家族成员生理生化功能研究
- 批准号:31670180
- 批准年份:2016
- 资助金额:65.0 万元
- 项目类别:面上项目
结合神经分类的分子超光谱成像生化指标定量分析研究
- 批准号:61240006
- 批准年份:2012
- 资助金额:10.0 万元
- 项目类别:专项基金项目
相似海外基金
Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies
髓系恶性肿瘤中致癌 NRAS 信号传导的新调控
- 批准号:
10467363 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别:
Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies
髓系恶性肿瘤中致癌 NRAS 信号传导的新调控
- 批准号:
10580053 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别:
Elucidating the Complexin C-terminal Domain Mechanism in Neurotransmission Regulation
阐明神经传递调节中的复合蛋白 C 末端结构域机制
- 批准号:
10624237 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别:
Dysregulation of iron homeostasis by mutant LRRK2 in human neurons
人类神经元中突变型 LRRK2 导致铁稳态失调
- 批准号:
10592478 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别: